Newsroom
Sorted by: Latest
-
Korea Newswire, インテリジェントPRプラットフォーム「MediaBee」をリリース
ソウル--(BUSINESS WIRE)--韓国最大級のメディアデータベースを基盤としたコミュニケーションプラットフォーム「MediaBee」が正式リリースされた。...
-
-
Korea Newswire Launches MediaBee, an Intelligent PR Platform Powered by Korea’s Largest Media Database
SEOUL, South Korea--(BUSINESS WIRE)--Korea Newswire, a leading PR distribution leader, launches MediaBee, an AI-powered PR intelligence platform leveraging Korea’s largest media database...
-
-
Lone Star Funds schließt Verkauf von SPX FLOW an ITT Inc. ab
DALLAS & NEW YORK & LONDON & TOKYO--(BUSINESS WIRE)--Lone Star Funds („Lone Star“) gab heute bekannt, dass eine Tochtergesellschaft von Lone Star Fund XI, L.P., den Verkauf von SPX FLOW, Inc. („SPX FLOW“), einem führenden Anbieter von hochtechnisierten Anlagen und Verfahrenstechnik für attraktive Endmärkte wie Industrie, Gesundheit und Ernährung, an ITT Inc. (NYSE: ITT) für 4,775 Milliarden US-Dollar in bar und ITT-Stammaktien erfolgreich abgeschlossen hat. SPX FLOW konzentriert sich auf Verfah...
-
Two GPWR-Litigated Matters Featured in Broadridge’s 2026 Global Class Action Annual Report’s Top 10 Most Complicated Recoveries of 2025
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”) announces that two matters the Firm litigated are spotlighted in Broadridge’s 2026 Global Class Action Annual Report among the “top 10 most complicated class action asset recovery opportunities of 2025”: Alibaba Group Holding Ltd. Securities Litigation ($433.5M) and ViacomCBS (Archegos) Securities Litigation ($120M). Congrats to the talented lawyers—Robert Prongay, Kara Wolke, Kevin Ruf, Melissa Wright, Pavithra Rajesh...
-
Sangfor Technologies Forges New Global Strategic Partnership with Cohesity to Redefine Business Resilience
HONG KONG--(BUSINESS WIRE)--Sangfor partners with Cohesity to deliver unified business resilience, offering integrated data protection and a seamless VMware alternative....
-
Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma’s morcamilast, a selective PDE4 inhibitor, was granted orphan medicinal product designation by the EC for palmoplantar pustulosis....
-
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
OSAKA, Japan & MONTREAL--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that it has entered into an agreement to expand the drug discovery collaboration agreement with Congruence Therapeutics (Headquarters: Montreal, Quebec, Canada; CEO: Clarissa Desjardins; “Congruence”) for the discovery of novel small molecule modulators against multiple protein targets in the areas of neurology and immunology. In December 2024, we entere...
-
Kyocera’s inkjet textile printer supports the sustainable fashion presented by Florania at Milan Fashion Week
OSAKA, Japan--(BUSINESS WIRE)--KYOCERA Document Solutions Italia S.p.A. (Managing Director: Noriyuki Nakatani) is pleased to announce that print technology from our sustainable inkjet textile printer “FOREARTH” has been adopted for the Fall/Winter 2026/2027 collection of the Italian fashion brand Florania. This collection was presented in Milan on Thursday, February 26, as Florania’s first runway show listed on the official Milan Fashion Week calendar, and it attracted significant attention fro...
